We evaluated the association between Nectin‐4 and ABC transporter expression in primary tumour samples, including both non‐muscle‐invasive and muscle‐invasive tumours, and PFS after EV therapy in all 20 patients. The gene discussed is ABCG2; the disease is neoplasm.